IMAX Sale Talks Pop Shares 15% and Rattle Hollywood Studios

IMAX Corporation shares closed up 15% at $39.12 on May 22 after the Wall Street Journal reported the company has held preliminary talks with potential buyers, including entertainment and technology firms. The premium-cinema operator finished 2025 with a record $1.28 billion in global box office, up 40% year over year, from a network of just over 1,800 locations.

Wall Street’s first instinct has been to draft a bidder list. The harder question, and the one rival studios are already running in private, is what happens to everyone who doesn’t win the auction.

Why IMAX Pulls 5% of Box Office From 1% of Screens

The asset on the block is closer to a licensing platform than a chain of cinemas. IMAX operates roughly 1,865 systems worldwide, about 1% of all commercial cinema screens. In 2025 those screens captured close to 5% of global ticket sales and 3.8% of the worldwide box office, the highest market share in the company’s history.

The 2025 record broke the previous high, set in 2019, by 13%. Box office from North American IMAX screens reached $449 million, China contributed $407 million, and international markets outside China delivered $427 million. The slate ran to 122 films, also a record, with 67 international titles from 14 countries pushing local-language box office to $405 million.

What makes the model unusual is that IMAX rarely owns the auditorium. It licenses projection systems, sound design, and the brand to operators like AMC Entertainment, Cinemark, and Wanda, then shares ticket revenue on titles released in its format. The headline product is a calibrated room and a release window, not real estate.

Mike Hickey of Benchmark Equity Research drew the implication in a note to clients after the May 22 report. “Imax operates less like a traditional theater chain and more like a premium entertainment technology platform,” he wrote, a line that has been quoted back in nearly every subsequent bidder profile, and one that the company’s 2025 box office milestone announcement already implied a quarter earlier.

The Four Bidder Buckets Wall Street Sees

Analyst notes since May 22 have sorted potential buyers into four groups. Each comes with a different strategic rationale and a different conflict profile, and the auction’s outcome will turn on which set the IMAX board prefers to negotiate against.

Alicia Reese, Wedbush analyst, named four categories in a client note: private equity, Netflix, Apple, and Sony Group. Her preference for private equity rests on what she calls platform neutrality. “PE ownership avoids the platform conflict issue entirely,” she wrote.

Eric Wold, Texas Capital Securities analyst, went further on the studio question. He told clients he would be “surprised if any of the major Hollywood studios” pursue a deal, given the fight for IMAX release windows already underway between competing tentpoles.

David Joyce of Seaport Research Partners has emphasized the cash question. “We truly hope it is going to be an all-cash deal for investors,” he wrote. Steve Frankel at Rosenblatt Securities went the other way and argued IMAX should remain independent, citing the platform’s pricing power as a standalone licensor.

None of the named analysts have offered an enterprise-value range publicly. IMAX’s market capitalization sat near $2.04 billion at the May 26 close, with a price-to-earnings multiple north of 50. Any premium would push the deal value into territory that narrows the realistic bidder pool to companies with multibillion-dollar cash positions or sovereign-backed financing.

Why a Studio Bid Sets Off the Rest of Hollywood

The reason studios are paying as much attention to who else might bid as to whether they should bid is simple math. IMAX runs about 122 films a year through roughly 1,800 screens, which means most weeks the network can host one major release in the format and at most two splits. A studio that owns IMAX owns first call on those weeks.

That allocation already drives backroom negotiation every release cycle, with studios competing for anchor IMAX windows around the same corridors. Coverage of premium-screen openings like the Mandalorian and Grogu theatrical rollout has tracked how marketing campaigns now lead with IMAX availability as much as with the cast, an indication of how much weight studios place on the format slot.

PE ownership avoids the platform conflict issue entirely.

The line is from Alicia Reese, Wedbush analyst, in her May 22 note. Reese has spent the week making a version of the same point in client conversations: a financial buyer keeps the format neutral and protects pricing power on all studios’ tentpoles, while a strategic buyer creates a structural advantage for one slate. A Disney or Comcast/NBCUniversal bid would draw the loudest objections from the rest of Hollywood, even before regulators look at it.

Q1 2026 Numbers a Buyer Would Inherit

The financial picture the IMAX board is taking into the talks is mixed. Q1 2026 revenue came in at $81.4 million, down about 6% from the same quarter a year earlier, as a tough comparison against China’s “Ne Zha 2” run from Q1 2025 wiped out most of the company’s regional contribution.

Outside Greater China, the underlying business kept growing. North America box office for the format rose 75%, the rest of world outside China rose 60%, and total ex-China box office was up 67%.

Greater China box office fell 62% on the year-ago compare. The headline that net global box office of $260 million was down 13% obscures that split, and is one reason the sale exploration arrived now rather than after the Q2 print.

Key Q1 markers from the IMAX Q1 2026 10-Q filing:

• $81.4 million in quarterly revenue, with gross profit of $45.8 million
• $90 million-plus of IMAX box office on Project Hail Mary alone, more than double the company’s initial projection
• 435 systems in installation backlog against a 1,865-system installed base
• $528 million in available liquidity heading into the second half

Management reaffirmed full-year 2026 guidance of $1.4 billion in global IMAX box office, which would put the network up about 9% year over year and roughly 12% above the previous 2019 peak. The guidance leans on a heavier back half of tentpoles than the prior year, with Q3 and Q4 carrying the variance.

Cost discipline showed up in the bottom line. Adjusted earnings per share landed at 17 cents, a slight beat on consensus, even as revenue fell. The mix is the profile a strategic buyer wants going into diligence: variable cost structure, retained pricing power, a network expansion runway, and a balance sheet with room to absorb capex without a financing event.

Gelfond’s Return and the Process Clock

Any auction process needs a seller. IMAX has one, but the timing of his return to the desk matters to the deal calendar more than the analyst notes acknowledge.

Richard Gelfond, IMAX’s chief executive since 2009, took a temporary medical leave in March 2026 as he was treated for pneumonia, the company said in a release on its investor site. By late April the company said he was gradually resuming leadership duties. Operations during the leave ran through CFO Natasha Fernandes and Board Chairman Darren Throop, both of whom hold institutional context on the diligence preparations now surfacing as preliminary talks.

Gelfond has run a prior strategic move during his tenure that did not produce an outright sale. In 2014 the company carved out IMAX China through a separate Hong Kong listing rather than a full divestiture, with CMC Capital Partners and FountainVest Partners taking a 20% stake for $80 million. The episode reinforced his preference for keeping the platform standalone, a stance Rosenblatt’s Steve Frankel echoed in his note this week.

What’s different now is the comparable set. Sphere Entertainment’s Las Vegas valuation, the willingness of tech platforms to pay strategic premiums for content-adjacent assets, and a depressed multiplex sector that makes standalone exhibition look fragile have all moved the math. A board that turned away interest at lower share prices in earlier cycles sees a different curve at $40.

The Auction Calendar Studios Are Watching

The clock that matters is the 2027 release slate. Studios begin locking IMAX windows 12 to 18 months ahead of release.

The 2027 summer corridor already has multiple announced franchise tentpoles competing for anchor IMAX weeks. Negotiations for those windows are happening now, in parallel with whatever the sale process becomes. A drawn-out process that runs into late 2026 could leave 2027 window allocations in limbo, which favors studios that already have signed window deals and disadvantages those still negotiating.

The company’s Q1 8-K release of operating commentary reaffirmed the $1.4 billion box-office target without mentioning the sale exploration, which is consistent with a process the board has not formally launched. The phrasing matters because formal launches trigger disclosure obligations the company would prefer to avoid until the bidder field is set.

If a strategic buyer prevails, premium release windows tighten for studios outside the owner’s slate by the 2027 summer corridor, and rev-share economics get renegotiated on every contract that comes up for renewal. If private equity or sovereign wealth wins, the licensing platform continues largely as-is, with the cultural calendar dictating the cash flow and the format staying neutral across studios. If the talks dissolve and IMAX stays independent, the question moves to whether the share price holds the May 22 reset or gives back the takeover premium.

The first real signal will be whether IMAX names a financial advisor in the next quarter. Until it does, the company sits in the part of an M&A process where everything is preliminary and nothing is binding, including the assumption that any of this finishes in a sale at all.